Our experienced consultants can provide insight on all regulatory requirements for France and address any questions related to:
- Drug Registration
- Early Access Programmes
- Post MAA activities
- Promotional material review
- Quality System & Audits
- Interactions with Healthcare professionals: Compliance with the French laws (DMOS, Transparence de liens, Charte de l’information promotionnelle)
- Pharmacovigilance
- Pricing & reimbursement
